ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,366Medicare Part D Prescriptions Filled, Including Refills

Rank: 125 out of 1006

$499K Total Retail Price of All Prescriptions

Rank: 228 out of 1006

464 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 464 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 464 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 8,845 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 419 396 1 1
WARFARIN SODIUM 378 367 2 8
AMLODIPINE BESYLATE 338 331 3 4
FUROSEMIDE 323 320 4 6
LEVOTHYROXINE SODIUM 312 286 5 2
METOPROLOL TARTRATE 302 291 6 7
LISINOPRIL 249 225 7 3
OMEPRAZOLE 232 220 8 9
DONEPEZIL HCL 208 203 9 17
ATENOLOL 205 187 10 13
ATORVASTATIN CALCIUM 197 193 11 5
HYDROCHLOROTHIAZIDE 193 180 12 11
NAMENDA 172 167 13 34
SERTRALINE HCL 156 156 14 19
ESCITALOPRAM OXALATE 152 149 15 27
METOPROLOL SUCCINATE 149 139 16 12
MIRTAZAPINE 147 147 17 26
PRAVASTATIN SODIUM 140 122 18 15
METFORMIN HCL 132 120 19 10
LOSARTAN POTASSIUM 116 105 20 22
TRAZODONE HCL 114 103 21 21
POTASSIUM CHLORIDE 111 111 22 30
CITALOPRAM HBR 111 109 22 24
GABAPENTIN 93 90 24 20
ZOLPIDEM TARTRATE 88 76 25 14
CARVEDILOL 84 84 26 36
QUETIAPINE FUMARATE 82 77 27 45
HYDROCODONE-ACETAMINOPHEN 81 77 S3 28 25
ENALAPRIL MALEATE 77 73 29 83
CRESTOR 75 71 30 18
ALENDRONATE SODIUM 74 62 31 29
TAMSULOSIN HCL 63 63 32 23
PREDNISONE 59 58 33 33
LOVASTATIN 59 53 33 44
ADVAIR DISKUS 57 54 35 37
AGGRENOX 56 56 36 203
HYDROCORTISONE 54 52 37 260
TRIAMTERENE-HCTZ 54 54 37 58
DIOVAN 52 40 39 16
LEXAPRO 52 46 39 103
AZITHROMYCIN 51 38 41 39
DIVALPROEX SODIUM 50 39 42 53
CLOPIDOGREL 50 50 42 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.